Abstract
The interferon (IFN) system is composed by a series of antiviral and cell modulating proteins newly produced by body cells stimulated by foreign substances.
There are three known antigenic types of IFN and a number of subtypes (for a general review see [41]): Alpha-IFN is produced by leukocytes induced by viruses, xenogenic or tumor cells, bacteria, and B-cell mitogens through a mechanism of interactions at cell surface [17], and can prevent spreading of viruses through the bloodstream and enhance the effectiveness of natural barriers (blood-brain, blood-lung, etc.). Beta-IFN is produced by fibroblast and epithelial cells during virus infections, viral RNA being the inducing factor. It diffuses poorly from solid tissues, quickly establishing the antiviral state in the neighboring cells. Gamma-IFN is produced by T cells stimulated by specific antigens or T cell mitogens. All IFNs must be secreted by the producing cell and bind from the outside to specific cell receptor.
Work supported in part by grants from CNR, Progetto Finalizzato Oncologia, Contratto No 84.00563.44, Progetto Finalizzato Controllo Malattie da Infezione, Contratto No 84.01849.52, and Progetto Finalizzato Ingegneria Genetica e Basi Molecolari delle Malattie Ereditarie, and by USPHS grants AI20251 and CAI7276 awarded by the National Institute of Allergy and Infectious Diseases and the National Cancer Institute, Department of Health and Human Services
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ameglio F, Capobianchi MR, Dolei A, Tosi R (1983) Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci. Infect Immun 42:122–125
Ameglio F, Dolei A, Capobianchi MR, Tosi R (1984) Preferential increase of expression and release of DC molecules in human cells treated with interferon. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing 1984. Springer, Berlin Heidelberg New York Tokyo, p 549
Attallah AM, Strong DM (1979) Differential effects of interferon on the MHC expression of human lymphocytes: enhanced expression of HLA without effect on la. Int Arch Allergy Appl Immunol 60:101–107
Basham TY, Bourgeade MF, Creasey A, Merigan TC (1983) Interferon increases HLA synthesis in melanoma cells: interferon resistant and sensitive cell lines. Proc Natl Acad Sci USA 79:3265–3269
Basham TY, Merigan TC (1983) Recombinant interferon gamma increases HLA-DR synthesis and expression. J Immunol 130:1492–1494
Basham TY, Smith W, Lanier L, Morhenn V, Merigan T (1984) Regulation of expression of class II major histocompatibility antigens on human peripheral blood monocytes and Langerhans cells by interferon. Hum Immunol 10:83–93
Becker S (1984) Interferons as modulators of human monocyte-macrophage differentiation. I. Interferon gamma increases HLA-DR expression and inhibits phagocytosis of zymosan. J Immunol 132:1249–1254
Beller DI, Kiely JM, Unanue ER (1980) Regulation of macrophage populations. I. Preferential induction of la-rich peritoneal exudates by immunologic stimuli. J Immunol 124:1426–1432
Beller DI (1984) Functional significance of the regulation of macrophage la expression. Eur J Immunol 2:138–143
Birmingham JR, Chesnut RW, Kappler JW, Marrak P, Kubo R, Grey HM (1982) Antigen presentation to T cell hybridomas by a macrophage cell line: an inducible function. J Immunol 128:1491–1492
Bodmer JG, Bodmer WF (1984) Monoclonal antibodies to HLA determinants. Br Med Bulletin 40:267–275
Bottazzo GF, Pujol-Burrel R, Hanafusa T, Feldmann N (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 11:1115–1119
Bondei M, Lamb JR, Bottazzo GF, Feldmann M (1984) Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312:639–641
Capobianchi MR, Ameglio F, Dolei A, Tosi R (1982) Expression of MHC products in human cell lines treated with interferons. In: Revoltella R, Pontieri GM, Basilico C, Rovera G, Gallo RM, Subak-Sharpe JH (eds) Expression of differentiated functions in cancer cells. Raven, New York, pp 457–487
Capobianchi MR, Ameglio F, Tosi R, Dolei A (1985) Differences in the expression and release of DR, BR, and DQ molecules in human cells trated with recombinant interferon gamma. Comparison to the other interferons. Hum Immunol 13:1–11
Capobianchi MR, Ameglio F, Tosi R, Dolei A (1984) Modulation of la antigens by interferons in human lymphoblastoid cells. In: Aaronson S, Frati L, Verna R (eds) Genetic and phenotypic markers of tumors. Plenum, New York, pp 217–222
Capobianchi MR, Facchini J, Di Marco P, Antonelli G, Dianzani F (1985) Induction of alpha interferon by membrane interaction between viral surface and peripheral blood mononuclear cells. Proc Soc Exp Biol Med 178:551–556
Collins T, Korman AS, Wake CT, Boss JM, Kappes DJ, Fiers W, Ault KA, Gimbrone MA Jr, Strominger JL, Pober JS (1984) Immune interferon activates multiple class II histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 81:4917–4921
Dianzani F, Zucca M, Scupham A, Georgiades J A (1980) Immune and virus-induced interferons may activate cells by different derepression mechanisms. Nature 283:400–402
Dolei A, Ameglio F, Capobianchi MR, Tosi R (1981) Human beta type interferon enhances the expression and shedding of la-like antigens. Comparison to HLA-A,B,C and Beta2-microglobulin. Antiviral Res 1:367–381
Dolei A, Capobianchi MR, Ameglio F (1983) Human interferon gamma enhances the expression and shedding of class I and class II MHC products in neoplastic cells better than interferon alpha and interferon beta. Infect Immun 40:172–176
Dolei A, Ameglio F, Capobianchi MR, Tosi R (1984) Membrane changes induced by interferons in human neoplastic cells. In: Aaronson S, Frati L, Verna R (eds) Genetic and phenotypic markers of tumors. Plenum, New York, pp 211–216
Dolei A, Ameglio F, Tosi R (1985) DQ locus products are the preferential la target for recombinant interferon gamma. In: Kirchner H, Schellekens H (eds) The biology of the interferon system. Elsevier, Amsterdam, pp 437–440
Fellous M, Nir U, Wallach D, Merlin G, Rubinstein M, Revel M (1982) Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci USA 79:3082–3086
Fleischmann RW (1982) Potentiation of the direct anticellular activity by mouse interferons: mutual synergism and interferon concentration dependence. Cancer Res 42:869–872
Folsom V, Gold DP, White J, Marrack P, Kappler J, Tonegawa S (1984) Functional and inducible expression of a transfected murine class II major histocompatibility complex gene. Proc Natl Acad Sci USA 81:2045–2049
Gerrard TL, Jurgensen CH, Fauci AS (1983) Differential effect of monoclonal anti-DR antibody on monocytes in antigen- and mitogen-stimulated responses: mechanisms of inhibition and relationship to Interleukin 1 secretion. Cell Immunol 82:394–402
Gerrard TL, Cupps TR, Jurgensen CH, Fauci AS (1984) Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigens. Cell Immunol 85:330–339
Giacomini P, Aguzzi A, Pestka S, Fisher PB, Ferrone S (1984) Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA and tumor-associated antigens by melanoma cells. J Immunol 133:1649–1655
Giacomini P, Aguzzi A, Ferrone S (1984) Changes in synthesis of MHC antigens induced by recombinant immune interferon (IFN gamma) in human melanoma cells. ASBC/AAI Meeting, St Louis, June 3–7, 1984
Gonwa TA, Picker LJ, Raff HV, Goyert SM, Silver J, Stobo JD (1983) Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an la determinant distinct from HLA-DR. J Immunol 130:706–711
Gonwa TA, Stobo JD (1984) Differential expression of la molecules by human monocytes. J Clin Invest 74:859–866
Hirschberg H, Braathen LR, Thorsby E (1982) Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol Rev 66:57–77
Houghton AN, Thomson TM, Gross D, Oettgen HF, Old LJ (1984) Surface antigens of melanoma and melanocytes. Specificity of induction of la antigens by human gamma interferon. J Exp Med 160:255–269
Hurley CK, Show S, Nadler L, Schlossmann S, Capra JD (1982) Alpha and beta chains of SB and DR antigens are structurally distinct. J Exp Med 156:1557–1569
Imai K, Ng AK, Glassy C, Ferrone S (1982) Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cell: relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J Immunol 127:505–508
Kauffman JF, Auffray C, Korman AJ, Shackelford DA, Strominger J (1984) The class II molecules of the human and murine major histocompatibility complex. Cell 36:1–26
Keley WE, Fiers W, Strom TB (1984) Cloned human interferon gamma, but not inter-feron-beta or -alpha, induces expression of HLA determinants by fetal monocytes and myeloid leukemic cell lines. J Immunol 132:240–244
Kim KJ, Chaouat G, Leiserson WM, King J, Maeyer E (1983) Characterization of T-cell soluble factors modulating the expression of la and H-2 antigens on BALB/c B lymphoma cell lines. Cell Immunol 76:253–267
King DP, Jones PP (1983) Induction of la and H-2 antigens on a macrophage cell line by immune interferon. J Immunol 131:315–318
Kirchner H, Schellekens H (eds) (1985) The biology of the interferon system. Elsevier, Amsterdam
Koch N, Wong GHW, Schrader JW (1984) la antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon gamma. J Immunol 132:1361–1369
Liao SK, Kwong PC, Khosravi M, Dent PB (1982) Enhanced expression of melanoma associated antigens and Beta2-microglobulin on cultured human melanoma cells by interferon. J Natl Cancer Inst 68:19–26
Lindhal P, Leary P, Gresser I (1972) Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci USA 69:721–725
Lindhal P, Leary P, Gresser I (1973) Enhancement by interferon of the expression of surface antigens on murine L1210 cells. Proc Natl Acad Sci USA 70:2785–2788
Lindhal P, Gresser I, Leary P, Tovey M (1976) Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc Natl Acad Sci USA 73:1284–1287
Lonai P, Steinman L (1977) Physiological regulation of antigen binding to T cell: role of a soluble macrophage factor and of interferon. Proc Natl Acad Sci USA 74:5662–5666
Lu CY, Unanue ER (1982) Spontaneous T-cell lymphokine production and enhanced macrophage la expression and tumoricidal activity in MLR-Lpr mice. Clin Immunol Immunopathol 25:313–222
McNicholas JM, King DP, Jones PP (1983) Biosynthesis and expression of la and H-2 antigens on a macrophage cell line are stimulated by products of activated spleen cells. J Immunol 130:449–456
Nakamura M, Manser T, Pearson GDN, Dalay MJ, Gefter ML (1984) Effect of the interferon-gamma on the immune response in vivo and on gene expression in vitro. Nature 307:381–382
Norcross MA, Bentley DM, Margulies DH, Germain RN (1984) Membrane la expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes. J Exp Med 160:1316–1337
Peterlin BM, Gonwa TA, Stobo JD (1984) Expression of HLA-DR by a human monocyte cell line is under transcriptional control. J Mol Cell Immunol 1:191–200
Pober JS, Gimbrone MA, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA (1983) la expression by vascular endothelium is induced by activated T cells and by human gamma interferon. J Exp Med 157:1339–1353
Pober JS, Collins T, Gimbrone MA, Cotran RS, Gitlin JD, Fiers W, Clayberger C, Krensky AM, Burakoff SJ, Reis CS (1983) Lymphocytes recognizes human vascular endothelial and dermal fibroblasts la antigens induced by recombinant immune interferon. Nature 305:726–729
Rhodes J, Stokes P (1982) Interferon-induced changes in the monocyte membrane: inhibition by retinol and retinoic acid. Immunology 45:531–538
Robbins PA, Brodsky FM, Warner NL, Maino VC (1984) Induction of class II antigens on monocytes cultured with gamma interferon. Dis Markers 2:267–279
Rosa F, Hatat D, Abadie A, Wallach D, Revel M, Fellous M (1983) Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon. EMBO J 9:1585–1589
Sher MG, Beller DI, Unanue ER (1980) Demonstration of a soluble mediator that induces exudates reach in la-positive macrophages. J Exp Med 152:1684–1690
Schook LB, Guttman DH, Marlin ME, Niederhuber JE (1984) In vitro-derived bone marrow macrophages. Expression of la antigens during macrophage differentiation. Transplantation 37:585–590
Smith BR, Ault K (1981) Increase of surface la-like expression on human monocytes independent of antigenic stimuli. J Immunol 127:2020–2027
Snyder DS, Lu CY, Unanue ER (1982) Control of macrophage la expression in neonatal mice: role of a splenic suppressor cell. J Immunol 128:1458–1465
Sonnenfeld G, Meruelo D, McDevitt HO, Merigan TC (1981) Effect of type I and type II interferons on murine thymocytes surface antigens expression: induction or selection? Cell Immunol 57:427–439
Steeg PS, Moore RN, Oppenheim J J (1980) Regulation of murine macrophage la antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin. J Immunol 129:2402–2406
Steeg PS, Moore RN, Johnson HM, Oppenheim J J (1982) Regulation of murine macrophage la antigen expression by a lymphokine with immune interferon activity. J Exp Med 156:1780–1796
Steinmann RM, Nogueira M, Witme MD, Tydings JD, Mellman IS (1980) Lymphokine enhances the expression and the synthesis of la antigens on cultured mouse peritoneal macrophages. J Exp Med 152:1248–1261
Sztein MB, Steeg PS, Johnson HM, Oppenheim JJ (1984) Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest 73:56565
Tanigaki N, Tosi R (1982) The genetic control of human la alloantigens: a three-loci model derived from immunochemical analysis of “supertypic” specificities. Immunol Rev 66:5–37
Thorsby E (1984) The role of HLA in T cell activation. Hum Immunol 9:1–7
Vignaux F, Gresser I (1978) Enhanced expression of histocompatibility antigens on in-terferon-treated mouse embryonic fibroblasts. Proc Soc Exp Biol Med 157:456–460
Virelizier JL, Perez N, Arenzana-Seisdedas F, Devos R (1984) Pure interferon gamma enhances class II HLA antigens on human monocyte lines. Eur J Immunol 14:106–108
Walker EB, Lanier LL, Warner NL (1982) Concomitant induction of the cell surface expression of la determinants and accessory cell function by a murine macrophage tumor cell line. J Exp Med 155:629–634
Wallach D, Fellous M, Revel M (1982) Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299:833–836
Wang CY, Al-Katib A, Lane CL, Kozinei B, Fu SM (1983) Induction of HLA-DC/DS (Leu 10) antigen expression by human precursor B cell lines. J Exp Med 158:1757–1762
Wong GHW, Clark-Lewis I, McKimm-Breschkin JL, Schrader JW (1982) Interferon-gamma-like molecules induce la antigens on cultured mast cell progenitors. Proc Natl Acad Sci USA 79:6989–6993
Wong GHW, Clark-Lewis I, McKimm-Breschkin JL, Harris AW, Schrader JW (1983) Interferon gamma induces enhanced expression of la and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J Immunol 131:788–793
Wong GHW, Clark-Lewis I, Hamilton JA, Schrader JW (1984) P cell stimulating factor and glucocorticoids oppose the action of interferon gamma in inducing la antigens on T-dependent mast cells (P cells). J Immunol 133:2043–2050
Wong GHW, Clark-Lewis I, Harris AW, Schrader JW (1984) Effect of cloned inter-feron-gamma on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic, and neuronal origin. Eur J Immunol 14:52–56
Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW (1984) Inducible expression of H-2 and la antigens on brain cells. Nature 310:688–691
Yem AW, Parmely MJ (1981) Modulation of la-like antigen expression and antigen-presenting activity of human monocytes by endotoxin and zymosan A. J Immunol 127:2245–2251
Ytterberg SR, Schnitzer TJ (1982) Serum interferon levels in patients with lupus erythematosus. Arthritis Rheum 25:401–410
Zlotnik A, Shimonkevitz RP, Gefter ML, Kappler J, Marrack P (1983) Characterization of the gamma-interferon-mediated induction of antigen presenting ability in P388D1 cells. J Immunol 131:2814–2820
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ameglio, F., Tosi, R., Tanigaki, N., Dolei, A. (1986). Modulation of Class II Antigens by Interferons. In: Solheim, B.G., Møller, E., Ferrone, S. (eds) HLA Class II Antigens. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70367-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-70367-6_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70369-0
Online ISBN: 978-3-642-70367-6
eBook Packages: Springer Book Archive